India Coronavirus Dispatch: Active caseload dips below 140,000

Front-line healthcare workers more enthusiastic about shots, SC refuses to entertain plea on fake vax, wearing two masks can boost protection, and more-news relevant to India's fight against Covid-19

Coronavirus, testing
File photo: A health worker collects a sample of a woman for Covid-19 test at a medical camp in Chennai
Bharath Manjesh New Delhi
3 min read Last Updated : Feb 12 2021 | 3:43 PM IST
IN NUMBERS: Active caseload under 140,000 

As many as 9,309 new coronavirus infections were recorded in the last 24 hours nationwide, taking the cumulative caseload to 1,08,80,603, according to a report in the Scroll. The fresh cases are 28% lower than Thursday’s count. 87 deaths were reported, taking the total death toll to 1,55,447, according to central health ministry data updated on Friday. The active caseload is at 1,35,926. The active caseload is under 140,000 for the first time since June last year. The national recovery rate has climbed to 97.32 per cent. About 7.5 million healthcare workers have been inoculated since the nationwide inoculation programme kicked off on January 16. Read more here


Vardhan allays fears flagged by Chhattisgarh health minister about Covaxin

Health Minister Harsh Vardhan made efforts to allay fears raised by his Chhattisgarh counterpart, T S Singh Deo, about Hyderabad-based vaccine maker Bharat Biotech's Covid-19 inoculant Covaxin, according to a report in the Scroll. Deo had requested Vardhan to halt the supply of the vaccine to Chhattisgarh due to "inhibition among the community" as the vaccine is yet to complete phase 3 trials. Deo also claimed the Covaxin vials did not carry expiry dates. Vardhan, in his response, said in a tweet, “in such unprecedented times, you should help address any vaccine hesitancy & do what’s in best interest of people, not further vested interests.” Read more here


Delhi: Front-line workers more enthusiastic about vaccination than health workers

A total of 15,807 recipients were administered Covid-19 vaccine in Delhi on Thursday, the highest so far, according to a report in The Hindu. The count includes both healthcare and front-line workers. Out of the total recipients, 12,933 (81.8%) were front-line workers. Front-line workers are showing more enthusiasm to get inoculated, according to a Delhi government official. Health workers include doctors, nurses, sanitation staff at healthcare facilities. Front-line workers include government employees, police, teachers and others. The vaccination of healthcare workers started in the city on January 16 and front-line workers from the first week of February, the report said. Read more here


SC refuses to entertain plea on fake Covid-19 vaccine

The Supreme Court refused to entertain a petition that sought a law to curb the sale of counterfeit Covid-19 vaccines and that of black marketing, a report in The Hindu said. Chief Justice of India Sharad A. Bobde told petitioner-advocate Vishal Tiwari, “We are not the legislature. We cannot pass general directions. Please bring a concrete case.” Read more here


Wearing two masks can boost protection

Research carried out by US health officials have shown that the use of two masks is likely to significantly cut exposure to coronavirus, a report in ThePrint.in said, citing the US Centers for Disease Control and Prevention (CDC). Masking up in two particular ways can boost protection. The first way is to wear a cloth mask over a surgical mask. The second way is to wear a single surgical face mask, by knotting the ear loops and tucking the sides in order to prevent air from leaking out, the report said. Read more here 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

Next Story